Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

INGN vs LNTH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
INGN
Inogen, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$193M
5Y Perf.-81.3%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$5.61B
5Y Perf.+527.5%

INGN vs LNTH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
INGN logoINGN
LNTH logoLNTH
IndustryMedical - DevicesDrug Manufacturers - Specialty & Generic
Market Cap$193M$5.61B
Revenue (TTM)$349M$1.54B
Net Income (TTM)$-23M$234M
Gross Margin47.6%61.1%
Operating Margin-8.7%20.2%
Forward P/E16.6x
Total Debt$17M$738K
Cash & Equiv.$104M$359M

INGN vs LNTHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

INGN
LNTH
StockMay 20May 26Return
Inogen, Inc. (INGN)10018.7-81.3%
Lantheus Holdings, … (LNTH)100627.5+527.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: INGN vs LNTH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LNTH leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Inogen, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
INGN
Inogen, Inc.
The Growth Play

INGN is the clearest fit if your priority is growth exposure.

  • Rev growth 3.9%, EPS growth 44.1%, 3Y rev CAGR -2.6%
  • 3.9% revenue growth vs LNTH's 0.5%
  • +0.6% vs LNTH's -17.8%
Best for: growth exposure
LNTH
Lantheus Holdings, Inc.
The Income Pick

LNTH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 0 yrs, beta 0.47
  • 40.0% 10Y total return vs INGN's -85.3%
  • Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthINGN logoINGN3.9% revenue growth vs LNTH's 0.5%
Quality / MarginsLNTH logoLNTH15.2% margin vs INGN's -6.5%
Stability / SafetyLNTH logoLNTHBeta 0.47 vs INGN's 1.10, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)INGN logoINGN+0.6% vs LNTH's -17.8%
Efficiency (ROA)LNTH logoLNTH10.8% ROA vs INGN's -7.6%, ROIC 30.6% vs -24.4%

INGN vs LNTH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

INGNInogen, Inc.

Segment breakdown not available.

LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M

INGN vs LNTH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLNTHLAGGINGINGN

Income & Cash Flow (Last 12 Months)

LNTH leads this category, winning 6 of 6 comparable metrics.

LNTH is the larger business by revenue, generating $1.5B annually — 4.4x INGN's $349M. LNTH is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to INGN's -6.5%.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…
RevenueTrailing 12 months$349M$1.5B
EBITDAEarnings before interest/tax-$10M$381M
Net IncomeAfter-tax profit-$23M$234M
Free Cash FlowCash after capex-$21M$349M
Gross MarginGross profit ÷ Revenue+47.6%+61.1%
Operating MarginEBIT ÷ Revenue-8.7%+20.2%
Net MarginNet income ÷ Revenue-6.5%+15.2%
FCF MarginFCF ÷ Revenue-6.1%+22.6%
Rev. Growth (YoY)Latest quarter vs prior year+2.0%+4.0%
EPS Growth (YoY)Latest quarter vs prior year+39.0%+5.8%
LNTH leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

INGN leads this category, winning 3 of 3 comparable metrics.
MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…
Market CapShares × price$193M$5.6B
Enterprise ValueMkt cap + debt − cash$107M$5.3B
Trailing P/EPrice ÷ TTM EPS-8.36x25.26x
Forward P/EPrice ÷ next-FY EPS est.16.59x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple13.78x
Price / SalesMarket cap ÷ Revenue0.55x3.64x
Price / BookPrice ÷ Book value/share1.01x5.41x
Price / FCFMarket cap ÷ FCF15.84x
INGN leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

LNTH leads this category, winning 7 of 8 comparable metrics.

LNTH delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-12 for INGN. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to INGN's 0.09x. On the Piotroski fundamental quality scale (0–9), INGN scores 6/9 vs LNTH's 5/9, reflecting solid financial health.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…
ROE (TTM)Return on equity-11.8%+20.6%
ROA (TTM)Return on assets-7.6%+10.8%
ROICReturn on invested capital-24.4%+30.6%
ROCEReturn on capital employed-13.3%+17.1%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.09x0.00x
Net DebtTotal debt minus cash-$86M-$358M
Cash & Equiv.Liquid assets$104M$359M
Total DebtShort + long-term debt$17M$738,000
Interest CoverageEBIT ÷ Interest expense16.89x
LNTH leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

LNTH leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $39,000 today (with dividends reinvested), compared to $1,077 for INGN. Over the past 12 months, INGN leads with a +0.6% total return vs LNTH's -17.8%. The 3-year compound annual growth rate (CAGR) favors LNTH at -3.1% vs INGN's -15.7% — a key indicator of consistent wealth creation.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…
YTD ReturnYear-to-date+7.2%+28.1%
1-Year ReturnPast 12 months+0.6%-17.8%
3-Year ReturnCumulative with dividends-40.0%-9.1%
5-Year ReturnCumulative with dividends-89.2%+290.0%
10-Year ReturnCumulative with dividends-85.3%+4002.4%
CAGR (3Y)Annualised 3-year return-15.7%-3.1%
LNTH leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

LNTH leads this category, winning 2 of 2 comparable metrics.

LNTH is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than INGN's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…
Beta (5Y)Sensitivity to S&P 5001.10x0.47x
52-Week HighHighest price in past year$9.13$108.91
52-Week LowLowest price in past year$5.34$47.25
% of 52W HighCurrent price vs 52-week peak+77.9%+79.1%
RSI (14)Momentum oscillator 0–10057.360.5
Avg Volume (50D)Average daily shares traded295K878K
LNTH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates INGN as "Buy" and LNTH as "Buy". Consensus price targets imply 265.7% upside for INGN (target: $26) vs 17.2% for LNTH (target: $101).

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$26.00$101.00
# AnalystsCovering analysts1117
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.3%
Insufficient data to determine a leader in this category.
Key Takeaway

LNTH leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). INGN leads in 1 (Valuation Metrics).

Best OverallLantheus Holdings, Inc. (LNTH)Leads 4 of 6 categories
Loading custom metrics...

INGN vs LNTH: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is INGN or LNTH a better buy right now?

For growth investors, Inogen, Inc.

(INGN) is the stronger pick with 3. 9% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 25. 3x trailing P/E (16. 6x forward), making it the more compelling value choice. Analysts rate Inogen, Inc. (INGN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — INGN or LNTH?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +290. 0%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: LNTH returned +40. 0% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — INGN or LNTH?

By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.

(LNTH) is the lower-risk stock at 0. 47β versus Inogen, Inc. 's 1. 10β — meaning INGN is approximately 135% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 9% for Inogen, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — INGN or LNTH?

By revenue growth (latest reported year), Inogen, Inc.

(INGN) is pulling ahead at 3. 9% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Inogen, Inc. grew EPS 44. 1% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — INGN or LNTH?

Lantheus Holdings, Inc.

(LNTH) is the more profitable company, earning 15. 2% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus -8. 7% for INGN. At the gross margin level — before operating expenses — LNTH leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is INGN or LNTH more undervalued right now?

Analyst consensus price targets imply the most upside for INGN: 265.

7% to $26. 00.

07

Which pays a better dividend — INGN or LNTH?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is INGN or LNTH better for a retirement portfolio?

For long-horizon retirement investors, Lantheus Holdings, Inc.

(LNTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 47)). Both have compounded well over 10 years (LNTH: +40. 0%, INGN: -85. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between INGN and LNTH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

INGN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 28%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform INGN and LNTH on the metrics below

Revenue Growth>
%
(INGN: 2.0% · LNTH: 4.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.